-+ 0.00%
-+ 0.00%
-+ 0.00%

Immuneering Chief Scientific Officer Brett Matthew Hall buys $25,045 of common shares

PUBT·06/16/2026 20:16:08
Listen to the news
Immuneering Chief Scientific Officer Brett Matthew Hall buys $25,045 of common shares
  • Immuneering Chief Scientific Officer Brett Matthew Hall bought 6,035 shares of Class A common stock at USD 4.15.
  • Direct ownership rose to 382,531 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001790340-26-000076), on June 16, 2026, and is solely responsible for the information contained therein.